When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Adverum Biotechnologies - Wikipedia

   en.wikipedia.org/wiki/Adverum_Biotechnologies

   It also changed its ticker symbol on the Nasdaq exchange from AAVL to ADVM. [8] In October 2016, former Annapurna Therapeutics CEO Amber Salzman became CEO of Adverum. [9] In May 2018, CEO Amber Salzman left Adverum, and Chief Medical Officer Athena Countouriotis resigned after less than one year in the job. [10]

3. Why Adverum Biotechnologies (ADVM) Might Surprise This ...

   www.aol.com/news/why-adverum-biotechnologies...

   Adverum Biotechnologies (ADVM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

4. Here's Why We're Watching Adverum Biotechnologies' (NASDAQ ...

   www.aol.com/news/heres-why-were-watching-adverum...

   For premium support please call: 800-290-4726 more ways to reach us

5. Ixoberogene soroparvovec - Wikipedia

   en.wikipedia.org/wiki/Ixoberogene_soroparvovec

   Ixoberogene soroparvovec (Ixo-vec, also known as ADVM-022), is a gene therapy developed by Adverum Biotechnologies for wet age-related macular degeneration. It is delivered via the viral vector AAV.7m8.

6. Hedge Funds Are Cashing Out Of Adverum Biotechnologies, Inc ...

   www.aol.com/news/hedge-funds-cashing-adverum...

   For premium support please call: 800-290-4726 more ways to reach us

7. What's in Store for Adverum (ADVM) This Earnings Season? - AOL

   www.aol.com/news/apos-store-adverum-advm...

   For premium support please call: 800-290-4726 more ways to reach us